Sankar Subramanian

Senior VP, Product DevelopmentNautilus Biotechnology, Inc. (NAUT) · full profile →Form 4 · filed Sep 28, 2022
Net Buying
Open-Market Buys
$30K
Open-Market Sells
$0
Net Open-Market Flow
$30K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 27, 2022Buy(P)5K$2.03$10K91K
Sep 26, 2022Buy(P)10K$2.03$20K86K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001808805-22-000101) within minutes of acceptance. Every field above traces to the original document. Verify it directly: